Page last updated: 2024-08-24

lumiflavin and Local Neoplasm Recurrence

lumiflavin has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wei, Z; Wu, S; Yang, R	1

Other Studies

1 other study(ies) available for lumiflavin and Local Neoplasm Recurrence

Article	Year
Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Flavins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; Riboflavin; Xenograft Model Antitumor Assays	2019

Article

Year

Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin.

Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:8

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Flavins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; Riboflavin; Xenograft Model Antitumor Assays

2019